BS Medicine Podcast
Hosted by
James McCormack
and
Mike Allan
These podcasts promote healthy skepticism and critical thinking, with the majority presented in a case-based format.
Listen Now
Recommended Listening
Episode 625: Blood Pressure Measurement Technique: Meaningful mistakes or minor details?
In episode 625, Mike K and James invite Danielle Perry and Tony Nickonchuk to the podcast to talk about the evidence around blood pressure measurement techniques. You might be surprised by what does and does not influence blood pressure measurements. Check out the podcast. Show Notes Tools For Practice Blood Pressure Measurement Technique: Meaningful mistakes […]...
Episode 624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?
In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to […]...
Episode 623: Less than 140, 130, or 120? Counting down to the optimal systolic blood pressure target
In episode 623, Jamie and James invite Samantha Moe back again to talk about the never-ending debate as to what is the target for systolic blood pressure. We look at the evidence and then try to put it into a reasonable context because at best the evidence is always nuanced. But at least you will […]...
Episode 622: Bronchodilator with Benefits? Budesonide-formoterol rescue inhaler for asthma
In episode 622, Jamie and James invite Émélie Braschi back again to talk about if we should be using inhalers that combine corticosteroids and beta-agonists as rescue inhalers. We go over the best available evidence and then try to put the findings into context. Show Notes Tools For Practice Bronchodilator with Benefits? Budesonide-formoterol rescue inhaler […]...
Episode 621: Whole-Body MRI for Cancer Screening: Many findings, little benefit
In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally the lost opportunity costs. You need to know these numbers to talk to your patients about the value or lack thereof of doing this test. […]...